Read more
April 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…
Read more
March 2023
In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more…
Read more
March 2023
JACC Review Topic of the Week. In this review the authors aim to summarize the role of PCAT in cardiac…
Read more
March 2023
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
Read more
March 2023
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…
Read more
February 2023
Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…
Read more
February 2023
Automated assessment of Epicardial adipose tissue (EAT) volume is possible in CCTA, including in patients who are technically challenging; it…
January 2023
BHF-funded researchers are paving the way towards future breakthroughs in heart disease research. Here are 5 big questions we’re helping…
Get in touch for more information.
